393 related articles for article (PubMed ID: 10478567)
21. Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor.
Martí D; Miquel R; Ziani K; Gisbert R; Ivorra MD; Anselmi E; Moreno L; Villagrasa V; Barettino D; D'Ocon P
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H1923-32. PubMed ID: 15951348
[TBL] [Abstract][Full Text] [Related]
22. Affinity profile at alpha(1)- and alpha(2)-adrenoceptor subtypes and in vitro cardiovascular actions of (+)-boldine.
Eltze M; Grebe T; Michel MC; Czyborra P; Ullrich B
Eur J Pharmacol; 2002 May; 443(1-3):151-68. PubMed ID: 12044805
[TBL] [Abstract][Full Text] [Related]
23. Effects of desipramine on prazosin potency at α1A- and α1D-adrenoceptors in rat vas deferens: implications for the α1L-adrenoceptor subclassification.
Docherty JR
Eur J Pharmacol; 2014 Dec; 744():183-9. PubMed ID: 25446564
[TBL] [Abstract][Full Text] [Related]
24. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
Errasti AE; Velo MP; Torres RM; Sardi SP; Rothlin RP
Br J Pharmacol; 1999 Jan; 126(2):437-42. PubMed ID: 10077236
[TBL] [Abstract][Full Text] [Related]
25. Characterization of subtype of alpha1-adrenoceptor mediating vasoconstriction in perfused rat hind limb.
Zhu W; Zhang Y; Han C
Eur J Pharmacol; 1997 Jun; 329(1):55-61. PubMed ID: 9218684
[TBL] [Abstract][Full Text] [Related]
26. The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries.
Ipsen M; Zhang Y; Dragsted N; Han C; Mulvany MJ
Eur J Pharmacol; 1997 Oct; 336(1):29-35. PubMed ID: 9384251
[TBL] [Abstract][Full Text] [Related]
27. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen.
Eltze M
Eur J Pharmacol; 1996 Sep; 311(2-3):187-98. PubMed ID: 8891599
[TBL] [Abstract][Full Text] [Related]
28. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.
Alexandre EC; Kiguti LR; Calmasini FB; Silva FH; da Silva KP; Ferreira R; Ribeiro CA; Mónica FZ; Pupo AS; Antunes E
Br J Pharmacol; 2016 Feb; 173(3):415-28. PubMed ID: 26493129
[TBL] [Abstract][Full Text] [Related]
29. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
[TBL] [Abstract][Full Text] [Related]
30. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
[TBL] [Abstract][Full Text] [Related]
31. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
Saussy DL; Goetz AS; Queen KL; King HK; Lutz MW; Rimele TJ
J Pharmacol Exp Ther; 1996 Jul; 278(1):136-44. PubMed ID: 8764344
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
Aboud R; Shafii M; Docherty JR
Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
[TBL] [Abstract][Full Text] [Related]
33. Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations.
Sathi ZS; Anisuzzaman AS; Morishima S; Suzuki F; Tanaka T; Yoshiki H; Muramatsu I
Eur J Pharmacol; 2008 Apr; 584(2-3):222-8. PubMed ID: 18336813
[TBL] [Abstract][Full Text] [Related]
34. The role of alpha1D-adrenoceptors in prostatic contraction examined using protection studies.
Chess-Williams R; Mason S; Sellers DJ; Wyllie M; Chapple CR
Auton Autacoid Pharmacol; 2002; 22(5-6):291-6. PubMed ID: 12866809
[TBL] [Abstract][Full Text] [Related]
35. Effect of cyproterone acetate on alpha1-adrenoceptor subtypes in rat vas deferens.
Campos M; Morais PL; Pupo AS
Braz J Med Biol Res; 2003 Nov; 36(11):1571-81. PubMed ID: 14576912
[TBL] [Abstract][Full Text] [Related]
36. Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed.
Martínez-Salas SG; Campos-Peralta JM; Pares-Hipolito J; Gallardo-Ortíz IA; Ibarra M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2007 Jul; 27(3):137-42. PubMed ID: 17584443
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous activation of the α1A-, α1B- and α1D-adrenoceptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats.
Aono Y; Taguchi H; Saigusa T; Uchida T; Takada K; Takiguchi H; Shirakawa T; Shimizu N; Koshikawa N; Cools AR
Behav Pharmacol; 2015 Feb; 26(1-2):73-80. PubMed ID: 25438092
[TBL] [Abstract][Full Text] [Related]
38. The pharmacology of α
Docherty JR
Eur J Pharmacol; 2019 Jul; 855():305-320. PubMed ID: 31067439
[TBL] [Abstract][Full Text] [Related]
39. Different roles of alpha1-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats.
Zhang Y; Yan J; Chen K; Song Y; Lu Z; Chen M; Han C; Zhang Y
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):626-33. PubMed ID: 15479171
[TBL] [Abstract][Full Text] [Related]
40. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Akers I; Coates J; Drew GM; Sullivan AT
Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]